Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $1.63 Million - $2.07 Million
7,129 New
7,129 $1.87 Million
Q2 2022

Jul 25, 2022

SELL
$230.71 - $256.74 $4.8 Million - $5.35 Million
-20,820 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$219.27 - $242.57 $4.16 Million - $4.6 Million
18,952 Added 1014.56%
20,820 $4.99 Million
Q4 2021

Jan 28, 2022

BUY
$198.88 - $227.6 $371,507 - $425,156
1,868 New
1,868 $420,000
Q4 2020

Feb 04, 2021

SELL
$216.38 - $257.67 $5.88 Million - $7 Million
-27,165 Closed
0 $0
Q3 2020

Nov 06, 2020

SELL
$234.65 - $260.95 $6.99 Million - $7.77 Million
-29,770 Reduced 52.29%
27,165 $6.9 Million
Q2 2020

Aug 11, 2020

BUY
$197.81 - $242.74 $8.07 Million - $9.9 Million
40,795 Added 252.76%
56,935 $13.4 Million
Q1 2020

May 08, 2020

SELL
$182.24 - $241.7 $1.21 Million - $1.61 Million
-6,646 Reduced 29.17%
16,140 $3.27 Million
Q4 2019

Feb 10, 2020

BUY
$189.21 - $243.2 $2.47 Million - $3.17 Million
13,050 Added 134.04%
22,786 $5.49 Million
Q3 2019

Oct 29, 2019

BUY
$174.11 - $208.62 $1.7 Million - $2.03 Million
9,736 New
9,736 $1.88 Million
Q2 2019

Jul 23, 2019

SELL
$166.7 - $195.41 $5.47 Million - $6.41 Million
-32,825 Closed
0 $0
Q1 2019

May 08, 2019

BUY
$180.87 - $203.88 $5.94 Million - $6.69 Million
32,825 New
32,825 $6.24 Million
Q4 2018

Feb 11, 2019

SELL
$178.4 - $208.25 $3.69 Million - $4.31 Million
-20,693 Closed
0 $0
Q3 2018

Oct 31, 2018

BUY
$185.29 - $208.89 $3.83 Million - $4.32 Million
20,693 New
20,693 $4.29 Million
Q1 2018

May 10, 2018

SELL
$169.43 - $198.0 $7.46 Million - $8.71 Million
-44,009 Closed
0 $0
Q4 2017

Feb 08, 2018

BUY
$168.79 - $188.59 $7.43 Million - $8.3 Million
44,009 New
44,009 $7.65 Million
Q3 2017

Nov 13, 2017

SELL
$167.29 - $191.0 $363,855 - $415,425
-2,175 Closed
0 $0
Q2 2017

Aug 10, 2017

BUY
N/A
2,175
2,175 $375,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wbi Investments, Inc. Portfolio

Follow Wbi Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wbi Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wbi Investments, Inc. with notifications on news.